- Home
- BHE vs CLDX Comparison
BHE vs CLDX Comparison
Compare BHE & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHE
- CLDX
- Stock Information
- Founded
- BHE 1979
- CLDX N/A
- Country
- BHE United States
- CLDX United States
- Employees
- BHE N/A
- CLDX N/A
- Industry
- BHE Electrical Products
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- BHE Technology
- CLDX Health Care
- Exchange
- BHE Nasdaq
- CLDX Nasdaq
- Market Cap
- BHE 1.4B
- CLDX 1.4B
- IPO Year
- BHE 1990
- CLDX 2008
- Fundamental
- Price
- BHE $40.56
- CLDX $22.08
- Analyst Decision
- BHE Strong Buy
- CLDX Strong Buy
- Analyst Count
- BHE 2
- CLDX 9
- Target Price
- BHE $46.50
- CLDX $46.13
- AVG Volume (30 Days)
- BHE 262.1K
- CLDX 1.5M
- Earning Date
- BHE 10-29-2025
- CLDX 08-07-2025
- Dividend Yield
- BHE 1.64%
- CLDX N/A
- EPS Growth
- BHE N/A
- CLDX N/A
- EPS
- BHE 1.05
- CLDX N/A
- Revenue
- BHE $2,588,733,000.00
- CLDX $5,790,000.00
- Revenue This Year
- BHE $0.18
- CLDX N/A
- Revenue Next Year
- BHE $6.65
- CLDX N/A
- P/E Ratio
- BHE $39.62
- CLDX N/A
- Revenue Growth
- BHE N/A
- CLDX N/A
- 52 Week Low
- BHE $30.73
- CLDX $14.40
- 52 Week High
- BHE $52.57
- CLDX $47.00
- Technical
- Relative Strength Index (RSI)
- BHE 54.99
- CLDX 47.99
- Support Level
- BHE $40.69
- CLDX $21.34
- Resistance Level
- BHE $41.52
- CLDX $23.27
- Average True Range (ATR)
- BHE 1.04
- CLDX 1.54
- MACD
- BHE 0.20
- CLDX -0.15
- Stochastic Oscillator
- BHE 74.67
- CLDX 33.75
About BHE Benchmark Electronics Inc.
Benchmark Electronics Inc is engaged in product designing, engineering services, technology solutions, and manufacturing services (electronic manufacturing services (EMS) and precision technology services). It serves various industries, including aerospace & defense (A&D), medical technologies, complex industrials, semiconductor capital equipment, next-generation telecommunications, and high-end computing. Its geographical segments are the Americas, Asia and Europe of which key revenue is derived from the Americas.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.